Efficacy and prognostic factors of first-line afatinib treatment for the EGFR-mutated non-small cell lung cancer in the real world

T. Chiu (Taoyuan, Taiwan), C. Huang (Taoyuan, Taiwan), C. Kuo (Taoyuan, Taiwan)

Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Session: Real-world data and registries of thoracic oncology
Session type: E-poster session
Number: 1687
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Chiu (Taoyuan, Taiwan), C. Huang (Taoyuan, Taiwan), C. Kuo (Taoyuan, Taiwan). Efficacy and prognostic factors of first-line afatinib treatment for the EGFR-mutated non-small cell lung cancer in the real world. 1687

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: